Tirzepatide, sold under the brand name Mounjaro, is used primarily for the treatment of type 2 diabetes and weight loss. Its dosing schedule involves a gradual increase to help manage potential side effects and optimize its effectiveness. Here’s a breakdown of the common dosing regimen for...

Tirzepatide, marketed under the brand name Mounjaro, is an injectable medication that has been gaining attention for its effectiveness in treating type 2 diabetes and its significant potential in weight loss. While it's primarily approved by the FDA for use in type 2 diabetes, many clinical...

For Type 2 Diabetes

• Starting Dose: 0.25 mg once weekly for 4 weeks; this dose is intended for treatment initiation and is not effective for glycemic control.
• Maintenance Dose: After the initial 4 weeks, increase to 0.5 mg once weekly. If additional glycemic control is needed,...

Semaglutide is primarily available as an injectable medication under the brand names Ozempic, Rybelsus, and Wegovy, used for the treatment of type 2 diabetes and weight loss. However, for those seeking non-injectable options, semaglutide is also available in an oral form:

Rybelsus is the...

Semaglutide, used both for type 2 diabetes management and weight loss, can have several potential side effects. Common side effects often relate to the gastrointestinal system but there are other considerations as well. Here’s a detailed look:

Common Side...

Semaglutide and tirzepatide are both effective medications used for weight management, but they work in slightly different ways and have different profiles that might make one more suitable than the other depending on individual health conditions and...

Weight regain after stopping semaglutide can vary depending on individual factors such as diet, exercise habits, and overall lifestyle. Semaglutide, used in the treatment of type 2 diabetes and for weight loss, works by regulating appetite and calorie intake, helping people to reduce their body...